A comparative study of intravenous labetalol VS intravenous nitroglycerin in the treatment of hypertensive crises [PDF]
Indian Heart Journal, 2022 Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but ...
Mohammad Azharuddin Malik +3 more
doaj +8 more sources
Comparative study of the effect of two different doses of intravenous labetalol on the cardiovascular response to endotracheal extubation [PDF]
Journal of Cardiovascular and Thoracic Research, 2023 Introduction: Providing a stable hemodynamic in extubation is important. We aimed to compare the effect of two different doses of intravenous labetalol on the cardiovascular response to endotracheal extubation. Methods: This double-blind randomized trial
Hamidreza Shetabi +3 more
doaj +3 more sources
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women. [PDF]
Afr Health Sci, 2023 Objectives: To compare the efficacy of intravenous Labetalol and intravenous Hydralazine in reduction of blood pressure in patients with severe pre-eclampsia. Methodology: This comparative study was conducted at the Department of Obstetrics and Gynecology at Ziauddin University Hospital, Karachi from1st June 2019 to 30th June 2020.
Kausar M, Husain S, Hussain R.
europepmc +6 more sources
Intravenous Labetalol vs Intravenous Clonidine for Attenuation of Haemodynamic Responses during Laryngoscopy and Intubation in Controlled Hypertensive Patients Undergoing General Anaesthesia- A Randomised Clinical Trial [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Laryngoscopy and endotracheal intubation during general anaesthesia are associated with haemodynamic surges which can be detrimental, particularly if there is pre-existing hypertension or cardiovascular disease. Intravenous (i.v.) labetalol,
Vijay Singh +4 more
doaj +2 more sources
Comparison of the efficacy of intravenous labetalol versus oral nifedipine in patients with severe pregnancy-induced hypertension beyond 30 weeks of gestation [PDF]
Journal of Family Medicine and Primary Care, 2023 Hypertensive disorders of pregnancy affect 5% to 10% of all pregnancies globally. The aim of treatment is to bring down blood pressure (BP) quickly and smoothly, which is safe for the mother and baby.
Manika Agarwal +4 more
doaj +2 more sources
Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients [PDF]
Journal of International Medical Research, 2023 Objectives Current evidence supporting the use of continuous intravenous labetalol for blood pressure (BP) control in neurosurgical patients is limited. This study aims to assess the efficacy and safety of labetalol in neurosurgical patients and identify
Raywat Noiphithak +4 more
doaj +2 more sources
Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension. [PDF]
Cureus, 2023 Background Hypertensive disorders of pregnancy are the leading causes of both maternal morbidity and maternal mortality. Hypertensive disorders are acute obstetric emergencies, which refer to various life-threatening medical challenges known to develop during pregnancy, labor, and delivery, requiring urgent attention to reduce blood pressure (BP) for ...
Ehikioya E +9 more
europepmc +3 more sources
Effectiveness and safety of intravenous labetalol in severe pre-eclampsia and eclampsia at a teaching institution in Chhattisgarh [PDF]
Journal of Family Medicine and Primary CareIntroduction: Severe hypertension in pregnancy deserves prompt recognition and urgent effective reduction in order to reduce the risk of complications such as eclampsia and HELLP syndrome and to achieve desirable neonatal outcomes.
Rachna Jain, Sangeeta Raman Jogi
doaj +2 more sources
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial [PDF]
BMJ Open, 2013 Objective To compare the efficacy of Food and Drug Administration recommended dosing of nicardipine versus labetalol for the management of hypertensive patients with signs and/or symptoms (S/S) suggestive of end-organ damage (EOD).Design Secondary ...
Brian Hiestand +14 more
doaj +2 more sources
The effect of intravenous labetalol administration on hemodynamic responses during desflurane inhalation [PDF]
Korean Journal of Anesthesiology, 2012 BackgroundInspired concentrations of desflurane ≥ 1 minimum alveolar anesthetic concentration (MAC) have been related to sympathetic stimulation such as hypertension and tachycardia.
Hyun-Seok Do +3 more
doaj +3 more sources